312 related articles for article (PubMed ID: 18978206)
1. Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.
Hulleman E; Kazemier KM; Holleman A; VanderWeele DJ; Rudin CM; Broekhuis MJ; Evans WE; Pieters R; Den Boer ML
Blood; 2009 Feb; 113(9):2014-21. PubMed ID: 18978206
[TBL] [Abstract][Full Text] [Related]
2. The synergism of MCL1 and glycolysis on pediatric acute lymphoblastic leukemia cell survival and prednisolone resistance.
Ariës IM; Hansen BR; Koch T; van den Dungen R; Evans WE; Pieters R; den Boer ML
Haematologica; 2013 Dec; 98(12):1905-11. PubMed ID: 24142999
[TBL] [Abstract][Full Text] [Related]
3. Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells.
Tissing WJ; den Boer ML; Meijerink JP; Menezes RX; Swagemakers S; van der Spek PJ; Sallan SE; Armstrong SA; Pieters R
Blood; 2007 May; 109(9):3929-35. PubMed ID: 17218380
[TBL] [Abstract][Full Text] [Related]
4. The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia.
Pottier N; Yang W; Assem M; Panetta JC; Pei D; Paugh SW; Cheng C; Den Boer ML; Relling MV; Pieters R; Evans WE; Cheok MH
J Natl Cancer Inst; 2008 Dec; 100(24):1792-803. PubMed ID: 19066270
[TBL] [Abstract][Full Text] [Related]
5. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment.
Holleman A; Cheok MH; den Boer ML; Yang W; Veerman AJ; Kazemier KM; Pei D; Cheng C; Pui CH; Relling MV; Janka-Schaub GE; Pieters R; Evans WE
N Engl J Med; 2004 Aug; 351(6):533-42. PubMed ID: 15295046
[TBL] [Abstract][Full Text] [Related]
6. Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia.
Spenerova M; Dzubak P; Srovnal J; Radova L; Burianova R; Konecny P; Salkova S; Novak Z; Pospisilova D; Stary J; Blazek B; Hak J; Votava T; Timr P; Kaiserova E; Bubanska E; Mihal V; Hajduch M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):422-7. PubMed ID: 23128824
[TBL] [Abstract][Full Text] [Related]
7. Expression of 11beta-hydroxysteroid dehydrogenase 2 contributes to glucocorticoid resistance in lymphoblastic leukemia cells.
Sai S; Nakagawa Y; Yamaguchi R; Suzuki M; Sakaguchi K; Okada S; Seckl JR; Ohzeki T; Chapman KE
Leuk Res; 2011 Dec; 35(12):1644-8. PubMed ID: 21794917
[TBL] [Abstract][Full Text] [Related]
8. NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells.
Paugh SW; Bonten EJ; Savic D; Ramsey LB; Thierfelder WE; Gurung P; Malireddi RK; Actis M; Mayasundari A; Min J; Coss DR; Laudermilk LT; Panetta JC; McCorkle JR; Fan Y; Crews KR; Stocco G; Wilkinson MR; Ferreira AM; Cheng C; Yang W; Karol SE; Fernandez CA; Diouf B; Smith C; Hicks JK; Zanut A; Giordanengo A; Crona D; Bianchi JJ; Holmfeldt L; Mullighan CG; den Boer ML; Pieters R; Jeha S; Dunwell TL; Latif F; Bhojwani D; Carroll WL; Pui CH; Myers RM; Guy RK; Kanneganti TD; Relling MV; Evans WE
Nat Genet; 2015 Jun; 47(6):607-14. PubMed ID: 25938942
[TBL] [Abstract][Full Text] [Related]
9. ENO2 Promotes Cell Proliferation, Glycolysis, and Glucocorticoid-Resistance in Acute Lymphoblastic Leukemia.
Liu CC; Wang H; Wang WD; Wang L; Liu WJ; Wang JH; Geng QR; Lu Y
Cell Physiol Biochem; 2018; 46(4):1525-1535. PubMed ID: 29689546
[TBL] [Abstract][Full Text] [Related]
10. Dual Mechanisms of Metabolism and Gene Expression of the CCRF-CEM Leukemia Cells under Glucocorticoid Treatment.
Lambrou GI; Karakonstantakis T; Vlahopoulos S; Zaravinos A
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072627
[TBL] [Abstract][Full Text] [Related]
11. Low dose of 2-deoxy-D-glucose kills acute lymphoblastic leukemia cells and reverses glucocorticoid resistance via N-linked glycosylation inhibition under normoxia.
Gu L; Yi Z; Zhang Y; Ma Z; Zhu Y; Gao J
Oncotarget; 2017 May; 8(19):30978-30991. PubMed ID: 28415682
[TBL] [Abstract][Full Text] [Related]
12. Pyruvate kinase M2 and prednisolone resistance in acute lymphoblastic leukemia.
Hulleman E; Broekhuis MJ; Pieters R; Den Boer ML
Haematologica; 2009 Sep; 94(9):1322-4. PubMed ID: 19734428
[No Abstract] [Full Text] [Related]
13. Circumvention of glucocorticoid resistance in childhood leukemia.
Haarman EG; Kaspers GJ; Pieters R; Rottier MM; Veerman AJ
Leuk Res; 2008 Sep; 32(9):1417-23. PubMed ID: 18395253
[TBL] [Abstract][Full Text] [Related]
14. Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia.
Stam RW; Den Boer ML; Schneider P; de Boer J; Hagelstein J; Valsecchi MG; de Lorenzo P; Sallan SE; Brady HJ; Armstrong SA; Pieters R
Blood; 2010 Feb; 115(5):1018-25. PubMed ID: 19965632
[TBL] [Abstract][Full Text] [Related]
15. 2-Deoxy-D-glucose Restore Glucocorticoid Sensitivity in Acute Lymphoblastic Leukemia via Modification of N-Linked Glycosylation in an Oxygen Tension-Independent Manner.
Leni Z; Ćwiek P; Dimitrova V; Dulcey AS; Zamboni N; Simillion C; Rossi G; Leibundgut K; Arcaro A
Oxid Med Cell Longev; 2017; 2017():2487297. PubMed ID: 28814986
[TBL] [Abstract][Full Text] [Related]
16. Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia.
Holleman A; den Boer ML; Kazemier KM; Janka-Schaub GE; Pieters R
Blood; 2003 Dec; 102(13):4541-6. PubMed ID: 12920041
[TBL] [Abstract][Full Text] [Related]
17. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children.
Koga Y; Matsuzaki A; Suminoe A; Hattori H; Kanemitsu S; Hara T
Pediatr Blood Cancer; 2005 Aug; 45(2):121-7. PubMed ID: 15704223
[TBL] [Abstract][Full Text] [Related]
18. In vitro drug sensitivity and expression profiling for disease prognostication in childhood acute lymphoblastic leukaemia (ALL): an exploratory model using cell lines.
Liu XG; Chen SP; Kham SK; Quah TC; Yeoh AE
Ann Acad Med Singap; 2004 Sep; 33(5 Suppl):S21-2. PubMed ID: 15651190
[No Abstract] [Full Text] [Related]
19. Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs.
Kaspers GJ; Pieters R; Van Zantwijk CH; Van Wering ER; Van Der Does-Van Den Berg A; Veerman AJ
Blood; 1998 Jul; 92(1):259-66. PubMed ID: 9639525
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo modulation of response to prednisolone in childhood acute lymphoblastic leukaemia.
Styczynski J; Wysocki M
Br J Haematol; 2006 May; 133(4):397-9. PubMed ID: 16643446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
